PKU HealthCare Corp.,Ltd. Company Description

PKU HealthCare Corp.,Ltd. engages in the research, development, production, and sale of chemical pharmaceutical preparations, pharmaceutical distribution, and medical services in China.

The company offers anti-infectives, analgesics, psychotropic drugs, digestive system drugs, and cardiovascular drugs; procurement and pharmacy outsourcing; and cancer screening, health management, and treatment services related to healthcare management and care delivery, as well as involved in distribution, retail, and hospital sales of pharmaceuticals, medical devices, and consumables.

It also provides ceftriaxone sodium, meropenem, and cefminox sodium for injection; moxifloxacin hydrochloride injection; clindamycin palmitate hydrochloride granules; naphazoline capsules; celecoxib capsules; dextroketoneprofen tablets and capsules; buspirone hydrochloride tablets; and olanzapine tablets.

The company was formerly known as PUK International Hospital Group Southwest Synthetic Pharmaceutical Corp., Ltd. and changed its name to PKU HealthCare Corp., Ltd. in November 2013.

PKU HealthCare Corp.,Ltd. was founded in 1993 and is headquartered in Chongqing, China.

PKU HealthCare Corp.,Ltd.

Country	China
Founded	1993
Industry	Drug Manufacturers - Specialty & Generic
Sector	Healthcare
Employees	789
CEO	Ping Dong Yuan

Contact Details

Address: Palm Springs International Center Chongqing, 401121 China
Phone	86 23 6301 4398
Website	pku-hc.com

Stock Details

Ticker Symbol	000788
Exchange	Shenzhen Stock Exchange
Fiscal Year	January - December
Reporting Currency	CNY
ISIN Number	CNE0000008M0
SIC Code	2834

Key Executives

Name	Position
Ping Dong Yuan	President and Non-Independent Director
Quan Bo Zhao	Vice President, Chief Financial Officer and Accounting Supervisor
Yu Fei Yuan	Secretary of the Board
Qing Kai He	Vice President
Mengchuan Yu	Vice President
Dr. Xiang Hong Chen	Vice President